Src Laboratories Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 9.94 Cr
as on 16-06-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.68 Cr
as on 16-06-2024
- Revenue 13.96%
(FY 2023)
- Profit 496.04%
(FY 2023)
- Ebitda 1003.09%
(FY 2023)
- Net Worth 117.87%
(FY 2023)
- Total Assets 18.45%
(FY 2023)
About Src Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.94 Cr.
The company currently has active open charges totaling ₹19.68 Cr.
Mohan Danda, Rama Yeluri, and Eluri Somireddy serve as directors at the Company.
- CIN/LLPIN
U73100TG2009PTC063850
- Company No.
063850
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2009
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Sultanpur, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Src Laboratories Private Limited offer?
Src Laboratories Private Limited offers a wide range of products and services, including Chemical Intermediates, Intermediate Chemicals.
Who are the key members and board of directors at Src Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rama Yeluri  | Managing Director | 02-Jun-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohan Danda | Whole-Time Director | 05-Jun-2017 | Current |
| Eluri Somireddy | Whole-Time Director | 02-Jun-2011 | Current |
Financial Performance and Corporate Structure Insights of Src Laboratories.
Src Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.96% increase. The company also saw a substantial improvement in profitability, with a 496.04% increase in profit. The company's net worth Soared by an impressive increase of 117.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Src Laboratories?
In 2023, Src Laboratories had a promoter holding of 71.99% and a public holding of 28.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ven Life Sciences Private LimitedActive 13 years 10 months
Rama Yeluri and Eluri Somireddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 10 Sep 2013 | ₹19.68 Cr | Open |
How Many Employees Work at Src Laboratories?
Src Laboratories has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Src Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Src Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
